Skip to main content
Clinical Trials/EUCTR2020-000595-37-CZ
EUCTR2020-000595-37-CZ
Active, not recruiting
Phase 1

Pharmacokinetics and pharmacodynamics of levobupivacaine during continuous caudal epidural analgesia in newborns - LEVO

Fakultní nemocnice v Motole0 sites60 target enrollmentStarted: June 25, 2020Last updated:

Overview

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Fakultní nemocnice v Motole
Enrollment
60

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Subjects fulfilling following criteria will be enrolled into the study during the 2 years time period.
  • ?Obtained informed consent of parent(s)/legal representative(s)
  • ?Age younger than 45th week of PMA
  • ?Previous or planned operation with great demand on POPM
  • ?Other diseases demanding great POPM (even without any need of surgery)
  • ?Vital functions of the patient will be stable and there will be no suspicion, that patient current condition might be worsen by insertion of c\-CELA (every patient will be discussed with attending physician )
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 60
  • F.1\.2 Adults (18\-64 years) no
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • ?Decline of informed consent by parent(s) legal representative
  • ?Age older than 45th week of PMA
  • ?Congenital malformation of caudal part of spine ( spina bifida oculta , meningocele, meningomyelocele)
  • ?Disease or congenital malformation significantly restricting liver functions (Elevation of liver enzymes more than twice above the physiological range of the corresponding PMA)
  • ?Disease or congenital malformation significantly restricting kidney functions (Elevation of urea and creatinine enzymes more than twice above the physiological range of the corresponding PMA)
  • ?Clinical condition, which doesn’t long\-term POPM
  • ? Patients with proven withdrawal syndrome caused by opiate administration
  • ?High risk of bleeding during insertion (coagulopathy)
  • ?Severe anemia, which would lead to blood transfusion due to taking of blood samples

Investigators

Sponsor
Fakultní nemocnice v Motole

Similar Trials